Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Premier who wrote (1257)	3/6/1998 11:26:00 PM
From: LPasko	Read Replies (1) \| Respond to of 2068

I assumed what is meant by this is that once Price was in, others also wanted in. With the company losing its "untouchable" status with investors, further financing became likely, removing the threat of bankruptcy.

To: Premier who wrote (1257)	3/7/1998 6:46:00 AM
From: Tony van Werkhooven	Respond to of 2068

I generally agree with you. The next near term downside risk will be from "guidance" by Oxford toward current year financial results. Given the reaction to the WSJ article, would not expect significant downside. The Templeton funds investment (Price) put no new money into the company, hence no impact on its capital position. Price research should have been based on publicly available information and any company guidance- should not have been based on insider information. Tony